ArticleAlzheimer's & dementia (New York, N. Y.)2022

Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials.

Ali Ezzati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.